The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Beta-Nicotinamide Mononucleotide Market Research Report 2025
Synopsis
The global Beta-Nicotinamide Mononucleotide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Beta-Nicotinamide Mononucleotide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Beta-Nicotinamide Mononucleotide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Beta-Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide.
Report Scope
The Beta-Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beta-Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Above 98%
Below 98%
Segment by Application
Health Care Products
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Beta-Nicotinamide Mononucleotide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Beta-Nicotinamide Mononucleotide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Beta-Nicotinamide Mononucleotide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Beta-Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide.
Report Scope
The Beta-Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beta-Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Above 98%
Below 98%
Segment by Application
Health Care Products
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Beta-Nicotinamide Mononucleotide Market Overview
1.1 Product Definition
1.2 Beta-Nicotinamide Mononucleotide Segment by Type
1.2.1 Global Beta-Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Beta-Nicotinamide Mononucleotide Segment by Application
1.3.1 Global Beta-Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Beta-Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Beta-Nicotinamide Mononucleotide Production Estimates and Forecasts (2019-2030)
1.4.4 Global Beta-Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Beta-Nicotinamide Mononucleotide Production Market Share by Manufacturers (2019-2024)
2.2 Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Beta-Nicotinamide Mononucleotide, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Beta-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Beta-Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide, Date of Enter into This Industry
2.9 Beta-Nicotinamide Mononucleotide Market Competitive Situation and Trends
2.9.1 Beta-Nicotinamide Mononucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Beta-Nicotinamide Mononucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Beta-Nicotinamide Mononucleotide Production by Region
3.1 Global Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Beta-Nicotinamide Mononucleotide Production Value by Region (2019-2030)
3.2.1 Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Beta-Nicotinamide Mononucleotide by Region (2025-2030)
3.3 Global Beta-Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Beta-Nicotinamide Mononucleotide Production by Region (2019-2030)
3.4.1 Global Beta-Nicotinamide Mononucleotide Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Beta-Nicotinamide Mononucleotide by Region (2025-2030)
3.5 Global Beta-Nicotinamide Mononucleotide Market Price Analysis by Region (2019-2024)
3.6 Global Beta-Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Beta-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
4 Beta-Nicotinamide Mononucleotide Consumption by Region
4.1 Global Beta-Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Beta-Nicotinamide Mononucleotide Consumption by Region (2019-2030)
4.2.1 Global Beta-Nicotinamide Mononucleotide Consumption by Region (2019-2024)
4.2.2 Global Beta-Nicotinamide Mononucleotide Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Beta-Nicotinamide Mononucleotide Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide Production by Type (2019-2030)
5.1.1 Global Beta-Nicotinamide Mononucleotide Production by Type (2019-2024)
5.1.2 Global Beta-Nicotinamide Mononucleotide Production by Type (2025-2030)
5.1.3 Global Beta-Nicotinamide Mononucleotide Production Market Share by Type (2019-2030)
5.2 Global Beta-Nicotinamide Mononucleotide Production Value by Type (2019-2030)
5.2.1 Global Beta-Nicotinamide Mononucleotide Production Value by Type (2019-2024)
5.2.2 Global Beta-Nicotinamide Mononucleotide Production Value by Type (2025-2030)
5.2.3 Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Type (2019-2030)
5.3 Global Beta-Nicotinamide Mononucleotide Price by Type (2019-2030)
6 Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide Production by Application (2019-2030)
6.1.1 Global Beta-Nicotinamide Mononucleotide Production by Application (2019-2024)
6.1.2 Global Beta-Nicotinamide Mononucleotide Production by Application (2025-2030)
6.1.3 Global Beta-Nicotinamide Mononucleotide Production Market Share by Application (2019-2030)
6.2 Global Beta-Nicotinamide Mononucleotide Production Value by Application (2019-2030)
6.2.1 Global Beta-Nicotinamide Mononucleotide Production Value by Application (2019-2024)
6.2.2 Global Beta-Nicotinamide Mononucleotide Production Value by Application (2025-2030)
6.2.3 Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Application (2019-2030)
6.3 Global Beta-Nicotinamide Mononucleotide Price by Application (2019-2030)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Beta-Nicotinamide Mononucleotide Corporation Information
7.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide Product Portfolio
7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Beta-Nicotinamide Mononucleotide Corporation Information
7.2.2 Herbalmax Beta-Nicotinamide Mononucleotide Product Portfolio
7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Genex Formulas
7.3.1 Genex Formulas Beta-Nicotinamide Mononucleotide Corporation Information
7.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide Product Portfolio
7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Genex Formulas Main Business and Markets Served
7.3.5 Genex Formulas Recent Developments/Updates
7.4 Shinkowa Pharmaceutical
7.4.1 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Corporation Information
7.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product Portfolio
7.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shinkowa Pharmaceutical Main Business and Markets Served
7.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Beta-Nicotinamide Mononucleotide Corporation Information
7.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product Portfolio
7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Maac10 Formulas Main Business and Markets Served
7.5.5 Maac10 Formulas Recent Developments/Updates
7.6 EffePharm
7.6.1 EffePharm Beta-Nicotinamide Mononucleotide Corporation Information
7.6.2 EffePharm Beta-Nicotinamide Mononucleotide Product Portfolio
7.6.3 EffePharm Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.6.4 EffePharm Main Business and Markets Served
7.6.5 EffePharm Recent Developments/Updates
7.7 Bontac
7.7.1 Bontac Beta-Nicotinamide Mononucleotide Corporation Information
7.7.2 Bontac Beta-Nicotinamide Mononucleotide Product Portfolio
7.7.3 Bontac Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Bontac Main Business and Markets Served
7.7.5 Bontac Recent Developments/Updates
7.8 CELFULL
7.8.1 CELFULL Beta-Nicotinamide Mononucleotide Corporation Information
7.8.2 CELFULL Beta-Nicotinamide Mononucleotide Product Portfolio
7.8.3 CELFULL Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CELFULL Main Business and Markets Served
7.7.5 CELFULL Recent Developments/Updates
7.9 Kingdomway
7.9.1 Kingdomway Beta-Nicotinamide Mononucleotide Corporation Information
7.9.2 Kingdomway Beta-Nicotinamide Mononucleotide Product Portfolio
7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Kingdomway Main Business and Markets Served
7.9.5 Kingdomway Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Beta-Nicotinamide Mononucleotide Industry Chain Analysis
8.2 Beta-Nicotinamide Mononucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Beta-Nicotinamide Mononucleotide Production Mode & Process
8.4 Beta-Nicotinamide Mononucleotide Sales and Marketing
8.4.1 Beta-Nicotinamide Mononucleotide Sales Channels
8.4.2 Beta-Nicotinamide Mononucleotide Distributors
8.5 Beta-Nicotinamide Mononucleotide Customers
9 Beta-Nicotinamide Mononucleotide Market Dynamics
9.1 Beta-Nicotinamide Mononucleotide Industry Trends
9.2 Beta-Nicotinamide Mononucleotide Market Drivers
9.3 Beta-Nicotinamide Mononucleotide Market Challenges
9.4 Beta-Nicotinamide Mononucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Beta-Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Beta-Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Beta-Nicotinamide Mononucleotide Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Beta-Nicotinamide Mononucleotide Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Beta-Nicotinamide Mononucleotide Production Market Share by Manufacturers (2019-2024)
Table 6. Global Beta-Nicotinamide Mononucleotide Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Beta-Nicotinamide Mononucleotide Production Value Share by Manufacturers (2019-2024)
Table 8. Global Beta-Nicotinamide Mononucleotide Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-Nicotinamide Mononucleotide as of 2023)
Table 10. Global Market Beta-Nicotinamide Mononucleotide Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Beta-Nicotinamide Mononucleotide Production Sites and Area Served
Table 12. Manufacturers Beta-Nicotinamide Mononucleotide Product Types
Table 13. Global Beta-Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Beta-Nicotinamide Mononucleotide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Region (2019-2024)
Table 18. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Beta-Nicotinamide Mononucleotide Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Beta-Nicotinamide Mononucleotide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global Beta-Nicotinamide Mononucleotide Production (Tons) by Region (2019-2024)
Table 22. Global Beta-Nicotinamide Mononucleotide Production Market Share by Region (2019-2024)
Table 23. Global Beta-Nicotinamide Mononucleotide Production (Tons) Forecast by Region (2025-2030)
Table 24. Global Beta-Nicotinamide Mononucleotide Production Market Share Forecast by Region (2025-2030)
Table 25. Global Beta-Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Beta-Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global Beta-Nicotinamide Mononucleotide Consumption by Region (2019-2024) & (Tons)
Table 29. Global Beta-Nicotinamide Mononucleotide Consumption Market Share by Region (2019-2024)
Table 30. Global Beta-Nicotinamide Mononucleotide Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global Beta-Nicotinamide Mononucleotide Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 34. North America Beta-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 35. Europe Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 37. Europe Beta-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific Beta-Nicotinamide Mononucleotide Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific Beta-Nicotinamide Mononucleotide Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 44. Global Beta-Nicotinamide Mononucleotide Production (Tons) by Type (2019-2024)
Table 45. Global Beta-Nicotinamide Mononucleotide Production (Tons) by Type (2025-2030)
Table 46. Global Beta-Nicotinamide Mononucleotide Production Market Share by Type (2019-2024)
Table 47. Global Beta-Nicotinamide Mononucleotide Production Market Share by Type (2025-2030)
Table 48. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Beta-Nicotinamide Mononucleotide Production Value Share by Type (2019-2024)
Table 51. Global Beta-Nicotinamide Mononucleotide Production Value Share by Type (2025-2030)
Table 52. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Type (2019-2024)
Table 53. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Type (2025-2030)
Table 54. Global Beta-Nicotinamide Mononucleotide Production (Tons) by Application (2019-2024)
Table 55. Global Beta-Nicotinamide Mononucleotide Production (Tons) by Application (2025-2030)
Table 56. Global Beta-Nicotinamide Mononucleotide Production Market Share by Application (2019-2024)
Table 57. Global Beta-Nicotinamide Mononucleotide Production Market Share by Application (2025-2030)
Table 58. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Beta-Nicotinamide Mononucleotide Production Value Share by Application (2019-2024)
Table 61. Global Beta-Nicotinamide Mononucleotide Production Value Share by Application (2025-2030)
Table 62. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2019-2024)
Table 63. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2025-2030)
Table 64. GeneHarbor Beta-Nicotinamide Mononucleotide Corporation Information
Table 65. GeneHarbor Specification and Application
Table 66. GeneHarbor Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. GeneHarbor Main Business and Markets Served
Table 68. GeneHarbor Recent Developments/Updates
Table 69. Herbalmax Beta-Nicotinamide Mononucleotide Corporation Information
Table 70. Herbalmax Specification and Application
Table 71. Herbalmax Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Herbalmax Main Business and Markets Served
Table 73. Herbalmax Recent Developments/Updates
Table 74. Genex Formulas Beta-Nicotinamide Mononucleotide Corporation Information
Table 75. Genex Formulas Specification and Application
Table 76. Genex Formulas Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Genex Formulas Main Business and Markets Served
Table 78. Genex Formulas Recent Developments/Updates
Table 79. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Corporation Information
Table 80. Shinkowa Pharmaceutical Specification and Application
Table 81. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Shinkowa Pharmaceutical Main Business and Markets Served
Table 83. Shinkowa Pharmaceutical Recent Developments/Updates
Table 84. Maac10 Formulas Beta-Nicotinamide Mononucleotide Corporation Information
Table 85. Maac10 Formulas Specification and Application
Table 86. Maac10 Formulas Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Maac10 Formulas Main Business and Markets Served
Table 88. Maac10 Formulas Recent Developments/Updates
Table 89. EffePharm Beta-Nicotinamide Mononucleotide Corporation Information
Table 90. EffePharm Specification and Application
Table 91. EffePharm Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. EffePharm Main Business and Markets Served
Table 93. EffePharm Recent Developments/Updates
Table 94. Bontac Beta-Nicotinamide Mononucleotide Corporation Information
Table 95. Bontac Specification and Application
Table 96. Bontac Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Bontac Main Business and Markets Served
Table 98. Bontac Recent Developments/Updates
Table 99. CELFULL Beta-Nicotinamide Mononucleotide Corporation Information
Table 100. CELFULL Specification and Application
Table 101. CELFULL Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. CELFULL Main Business and Markets Served
Table 103. CELFULL Recent Developments/Updates
Table 104. Kingdomway Beta-Nicotinamide Mononucleotide Corporation Information
Table 105. Kingdomway Specification and Application
Table 106. Kingdomway Beta-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Kingdomway Main Business and Markets Served
Table 108. Kingdomway Recent Developments/Updates
Table 109. Key Raw Materials Lists
Table 110. Raw Materials Key Suppliers Lists
Table 111. Beta-Nicotinamide Mononucleotide Distributors List
Table 112. Beta-Nicotinamide Mononucleotide Customers List
Table 113. Beta-Nicotinamide Mononucleotide Market Trends
Table 114. Beta-Nicotinamide Mononucleotide Market Drivers
Table 115. Beta-Nicotinamide Mononucleotide Market Challenges
Table 116. Beta-Nicotinamide Mononucleotide Market Restraints
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Beta-Nicotinamide Mononucleotide
Figure 2. Global Beta-Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Beta-Nicotinamide Mononucleotide Market Share by Type: 2023 VS 2030
Figure 4. Above 98% Product Picture
Figure 5. Below 98% Product Picture
Figure 6. Global Beta-Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Beta-Nicotinamide Mononucleotide Market Share by Application: 2023 VS 2030
Figure 8. Health Care Products
Figure 9. Cosmetics
Figure 10. Others
Figure 11. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Beta-Nicotinamide Mononucleotide Production Value (US$ Million) & (2019-2030)
Figure 13. Global Beta-Nicotinamide Mononucleotide Production Capacity (Tons) & (2019-2030)
Figure 14. Global Beta-Nicotinamide Mononucleotide Production (Tons) & (2019-2030)
Figure 15. Global Beta-Nicotinamide Mononucleotide Average Price (US$/Ton) & (2019-2030)
Figure 16. Beta-Nicotinamide Mononucleotide Report Years Considered
Figure 17. Beta-Nicotinamide Mononucleotide Production Share by Manufacturers in 2023
Figure 18. Beta-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Beta-Nicotinamide Mononucleotide Revenue in 2023
Figure 20. Global Beta-Nicotinamide Mononucleotide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Beta-Nicotinamide Mononucleotide Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Beta-Nicotinamide Mononucleotide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 23. Global Beta-Nicotinamide Mononucleotide Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Beta-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Beta-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Beta-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Beta-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Global Beta-Nicotinamide Mononucleotide Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 29. Global Beta-Nicotinamide Mononucleotide Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 31. North America Beta-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 32. Canada Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 33. U.S. Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. Europe Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 35. Europe Beta-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 36. Germany Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 37. France Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. U.K. Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. Italy Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. Russia Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Asia Pacific Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Asia Pacific Beta-Nicotinamide Mononucleotide Consumption Market Share by Regions (2019-2030)
Figure 43. China Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 44. Japan Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. South Korea Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. China Taiwan Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. Southeast Asia Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. India Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 52. Brazil Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. Turkey Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. GCC Countries Beta-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. Global Production Market Share of Beta-Nicotinamide Mononucleotide by Type (2019-2030)
Figure 56. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide by Type (2019-2030)
Figure 57. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Type (2019-2030)
Figure 58. Global Production Market Share of Beta-Nicotinamide Mononucleotide by Application (2019-2030)
Figure 59. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide by Application (2019-2030)
Figure 60. Global Beta-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2019-2030)
Figure 61. Beta-Nicotinamide Mononucleotide Value Chain
Figure 62. Beta-Nicotinamide Mononucleotide Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
